세계 척수 손상 치료제 시장 : 약제 유형별, 적응증별, 용도별, 투여 경로별, 유통 채널별, 지역별

Spinal Cord Injury Therapeutics Market, By Drug Type, By Indication, By Application, By Route of Administration, By Distribution Channel, By Geography

US $ 4,500 ￦ 6,451,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 10,035,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,337,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 척수 손상 치료제 시장 규모는 2023년에 74억 달러로 추정·예측되며, 예측기간 중(2023-2030년) CAGR은 5.4%로 예측됩니다.

보고 대상 범위		보고서 세부정보
기준년도	2022년	2023년 시장 규모	74억 달러
과거 데이터	2018-2021년	예측 기간	2023-2030년
예측 기간의 CAGR	5.40%	2030년 시장 규모 예측	107억 달러

그림 1. 세계 척수 손상 치료제 시장 점유율(%), 적응증별, 2023년

척수손상이란 31쌍의 척수신경에 생기는 상처로, 척수신경은 정신으로부터의 신경신호를 신체의 다양한 부위에 전달하는 동시에 팔과 다리의 발육을 제어하고 있습니다. 척수의 상처의 기본 원인은 상해, 척수에 혈액 공급의 손실, 암과 오염으로 인한 척수의 압박 등입니다. 척수의 상처는 예를 들어 X 빔, 어트랙티브 리버브레이션 레코드(MRI), 피규어 토모그래피(CT) 등 다양한 방법의 도움으로 판단할 수 있습니다. 제약 산업의 주요 기업은 척수 손상의 치료와 관련된 약물의 개발에 주력하고 있습니다. 따라서 이러한 첨단 제품이 시장에 도입됨으로써 예측 기간 동안 세계 척수 손상 치료제 시장의 성장이 촉진될 것으로 예상됩니다.

시장 역학

제약 업계의 주요 기업은 척수 손상 치료를 위한 신약 개발에 주력하고 있습니다. 따라서 이러한 첨단 제품이 시장에 도입됨으로써 예측 기간에 걸쳐 세계 척수 손상 치료제 시장의 성장이 촉진될 것으로 예상됩니다. 예를 들어 2022년 6월 완전 통합형 필수 의약품 기업인 Amneal Pharmaceuticals, Inc. 바클로펜 경구 과립(5, 10, 20mg) 전문 제품인 LYVISPAH의 상업적 출시를 발표했습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계 척수 손상 치료제 시장을 상세하게 분석하여 2022년을 기준년으로 한 예측기간(2023-2030년) 시장 규모 및 연간 평균 성장률(CAGR)을 제공합니다. 또한 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 행렬에 대해 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
• 세계 척수 손상 치료제 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 기반으로 프로파일링합니다.
• 본 연구의 대상이 되는 주요 기업은 Teva Pharmaceutical Industries Ltd., AbbVie Inc., Pfizer Inc., Reddy's Laboratories Ltd., Zydus Cadila, ReNetX Bio, Inc., InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc., Kringle Pharma, Inc, NervGen, Rising Pharmaceuticals, ScieGen Pharmaceuticals, MSN Laboratories Private Limited, Lannett Co Inc.
• 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 척수 손상 치료제 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참여자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 척수 손상 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제

• 조사의 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 시장 기회
• 영향 분석
• 최근 테스트 발사
• 역학
• 합병, 인수 및 협업
• 규제 시나리오
• 주요 발전
• PEST 분석

제4장 세계 척수 손상 치료제 시장 : COVID-19 영향 분석

• 경제적 영향
• 신형 코로나 바이러스 감염증(COVID-19)의 역학
• 수요 및 공급에 미치는 영향

제5장 세계 척수 손상 치료제 시장 : 약제 유형별(2018-2030년)

• 코르티코스테로이드
• 근육 이완제 및 항 경련제
• 비스테로이드성 항염증제(NSAID'S)
• 항우울제
• 항경련제
• 기타

제6장 세계 척수 손상 치료제 시장 : 적응증별(2018-2030년)

• 완전 척수 손상
• 불완전 척수 손상

제7장 세계 척수 손상 치료제 시장 : 용도별(2018-2030년)

• 자율신경실조증(AD)
• 경련과 염증
• 통증 관리
• 우울

제8장 세계 척수 손상 치료제 시장 : 투여 경로별(2018-2030년)

• 경구
• 정맥내

제9장 세계 척수 손상 치료제 시장 : 유통 채널별(2018-2030년)

• 병원 약국
• 소매 약국
• 온라인 약국

제10장 세계 척수 손상 치료제 시장 : 지역별(2018-2030년)

• 북미
• 미국
• 캐나다
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN
• 호주
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 중동
• GCC
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙 아프리카
• 남아프리카

제11장 경쟁 구도

• 기업 프로파일
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

제12장 섹션

• 참고문헌
• 조사 방법

JHS

영문 목차

영문목차

The Global Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 7.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.40%	2030 Value Projection:	US$ 10.7 Bn

Figure 1. Global Spinal Cord Injury Therapeutics Market Share (%), By Indication, 2023

Spinal cord wounds are the wounds caused to the 31 sets of spinal nerves, which convey nerve signals from the mind to different parts of the body and likewise control the arm and leg developments. The fundamental driver of spinal cord wounds incorporate injury, loss of blood supply to the spinal cord, and pressure in the spinal cord because of cancer or contamination. Spinal cord wounds can be determined to have the assistance of different methods, for example, X-beam, attractive reverberation record (MRI), and figured tomography (CT). Key players in the pharmaceutical industry are focusing on the development of drugs associated with the treatment of spinal cord injuries. Thus, the introduction of such advanced products in the market is expected to drive the growth of the global spinal cord injury therapeutics market over the forecast period.

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of new drugs for spinal cord injury treatment. Thus, the introduction of such advanced products in the market is expected to drive growth of the global spinal cord injury therapeutics market over the forecast period. For instance, in June 2022, Amneal Pharmaceuticals, Inc., a fully integrated essential medicines company, announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.

Key features of the study:

• This report provides an in-depth analysis of the global spinal cord injury therapeutics market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global spinal cord injury therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Global Spinal Cord Injury Therapeutics Market Detailed Segmentation:

• By Drug Type:
  • Corticosteroids
  • Muscle Relaxants and Anti-spastic drugs
  • Non-steroidal Anti-inflammatory drugs (NSAID'S)
  • Anti-depressants
  • Anticonvulsants
  • Others
• By Indication:
  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury
• By Application:
  • Autonomic Dysreflexia (AD)
  • Spasticity and Inflammation
  • Pain Management
  • Depression
• By Route of Administration:
  • Oral
  • Intravenous
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Indication
  • Market Snippet, By Application
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Muscle Relaxants and Anti-spastic Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Non-steroidal Anti-inflammatory Drugs (NSAID'S)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Anti-depressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Anticonvulsants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Complete Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Incomplete Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

7. Global Spinal Cord Injury Therapeutics Market, By Application, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Autonomic Dysreflexia (AD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Spasticity and Inflammation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

10. Global Spinal Cord Injury Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

12. Section

• References
• Research Methodology
• About us and Sales Contact

관련자료